Drimane Sesquiterpenoids Noncompetitively Inhibit Human α4β2 Nicotinic Acetylcholine Receptors with Higher Potency Compared to Human α3β4 and α7 Subtypes

Hugo R. Arias, Dominik Feuerbach, Bernd Schmidt, Matthias Heydenreich, Cristian Paz, Marcelo O. Ortells

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Fingerprint

Dive into the research topics of 'Drimane Sesquiterpenoids Noncompetitively Inhibit Human α4β2 Nicotinic Acetylcholine Receptors with Higher Potency Compared to Human α3β4 and α7 Subtypes'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds